在Mycobacterium的肺病治疗结果:一个系统的审查
Albert Yick Hou Lim1,2,3,4, Kevin Pethe3,5,6, Cheryl Hui Ling Khoong1
1Department of Respiratory and Critical Care Medicine, Tan Tock Seng Hospital, Singapore.
Annals of the Academy of Medicine, Singapore
|December 20, 2025
概括
目前用于治疗Mycobacterium abscessus complex (MABC) 肺部疾病的治疗方法显示出低于最佳的结果. 需要进一步进行大规模前性研究,以改善对这种新兴抗生素耐药威胁的患者护理.
科学领域:
- 传染性疾病 传染性疾病
- 微生物学 微生物学
- 肺部医学 肺部医学
背景情况:
- 由于显著的抗生素耐药性,Mycobacterium abscessus complex (MABC) 呈现出日益严重的全球健康挑战.
- 对MABC肺部疾病的有效治疗策略是有限的,需要对当前方法进行审查.
研究的目的:
- 系统地审查对MABC肺部疾病的现有治疗方案.
- 评估与当前的MABC治疗策略相关的临床结果.
主要方法:
- 在PubMed,Embase和Cochrane数据库中对2010年1月至2024年12月期间发表的研究进行了全面的文献搜索.
- 28项研究,包括回顾性和前性设计,符合纳入标准.
主要成果:
- 唾液培养转化率差异很大 (29%-77%),放射性 (33%-54%) 和临床改善 (14%-91%) 的情况也是如此.
- Mycobacterium massiliense感染的结果比M.疹感染的结果更好.
- 在耐火病例中,手术干预与更高的唾液培养转化率有关.
结论:
- 目前对MABC肺部疾病的治疗策略产生了低于最佳的结果.
- 需要标准化,大规模的前性研究,统一的治疗方案,以提高患者的治疗结果.
相关概念视频
Pulmonary Tuberculosis V
523
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
523
Pulmonary Tuberculosis II
1.3K
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
1.3K
Pulmonary Tuberculosis IV
468
Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
468
Pulmonary Tuberculosis III
890
Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
The first classification is based on the development of the disease, and it includes the following categories:
890
Pneumonia IV: Management
726
The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
726
Pulmonary Tuberculosis I
802
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
802


